pharmanewsdaily
1509 posts
Exonics Therapeutics receives $5m seed funding to advance Duchenne Muscular Dystrophy therapy
Exonics Therapeutics, a biotechnology firm based in Boston, Massachusetts, has secured $5 million in seed funding from CureDuchenne…
February 28, 2017
Cyclacel Pharmaceuticals’ sapacitabine fails to meet primary endpoint in Phase 3 blood cancer trial
Cyclacel Pharmaceuticals, a New Jersey-based biopharmaceutical company, announced that its experimental blood cancer drug, sapacitabine (CYC682), did not…
February 26, 2017
Symic Bio initiates SB-030 Phase 1/2a study in peripheral artery disease
Symic Bio, a biopharmaceutical company based in California specializing in matrix biology, is set to commence a phase…
February 25, 2017
FDA accelerates review of Novartis’s Zykadia for first-line treatment in lung cancer
Novartis AG, a prominent Swiss pharmaceutical company, has received a significant regulatory boost as its lung cancer medication,…
February 25, 2017
Pfizer’s inotuzumab ozogamicin gains FDA priority review in acute lymphoblastic leukemia
Pfizer Inc. has received a priority review designation from the U.S. Food and Drug Administration (FDA) for its…
February 23, 2017
Getting Involved in Preventing Pediatric Medication Errors
Visiting the doctor is not often an enjoyable experience, as it is typically prompted by a health concern…
February 17, 2017
Flonase Sensimist : GSK Consumer Healthcare launches new OTC allergy relief spray
GSK Consumer Healthcare, a division of GlaxoSmithKline PLC, has introduced a new over-the-counter (OTC) allergy relief nasal spray,…
February 11, 2017
Green Tea, the magic potion to treat bone-marrow diseases
Recent studies by the researchers of Washington University of St Louis along with their German collaborators have found…
February 7, 2017
Genprex announces promising results for Oncoprex in Phase II lung cancer trial
Texas-based biopharmaceutical company Genprex has unveiled positive interim data from an ongoing phase II clinical trial, NCT01455389, for…
January 7, 2017
Slayback Pharma launches Generic Zovirax Ointment for genital herpes in US
Slayback Pharma LLC has announced the launch of its new generic treatment for genital herpes, Generic Zovirax Ointment…
December 25, 2016